Cancer Vaccine Institute News

The UW Cancer Vaccine Institute is excited to share new findings suggesting that a HER2-targeted cancer vaccine may help protect HER2-positive breast cancer patients from developing brain metastases—one of the most difficult complications to treat. Dr. Candace Haghighi presented these findings at the 2025 San Antonio Breast Cancer Symposium. Dr. Candace B. Haghighi at the 2025 San Antonio Breast Cancer Symposium The Highlights: HER2-positive breast cancer has a high risk of s

Photo Credits: Jennifer Childs and Kiran Dhillon The Cancer Vaccine Institute held our first ever patient reunion during the CVI Circle - Empowering Patients, Advancing Science event last week in Seattle and virtually. Festivities kicked off with an informal dinner for CVI patients and family members, along with key CVI faculty and staff, on the evening of Thursday, June 15th. Patients were very excited to meet others who had gone through the same or similar clinical trials f

Friday, June 15th-16th, 2023 In-person in Seattle, Washington & Virtually The CVI Circle - Empowering Patients, Advancing Science ("The CVI Circle") is an event organized by the Cancer Vaccine Institute at the University of Washington to bring together patients, clinicians, and researchers. We are proud to partner with our amazing Patient Advisory Council the planning of this event. Our goal is for everyone - patients, clinicians, & scientists - to have the opportunity to pa

Dr. Denise Cecil, CVI Principal Scientist, was awarded an honorable mention for her abstract and presentation of her work on the link...

Gizmodo, the science, technology, and design website, selected the Cancer Vaccine Institute as a winner of the 2023 Gizmodo Science Fair...